Indian Drugs and Dietary Supplements facing increasing USFDA Bans
New Delhi: A number of Indian Medicinal products were denied admission into the american market between January 2011 and February 2016 by USFDA. Information to this effect was given to the parliament on Wednesday.The bar was implemented by the US health regulator who refused entry of 11,664 Indian products, inclusive of drugs & dietary supplements due to branding, packaging,labelling and adulteration issues.
"According to refusal report data available on the US Food and Drug Administration (USFDA) website, 11,664 refusals of Indian products were recorded from January 2011 to February 2016," Minister of State for Commerce and Industry Nirmala Sitharaman on Wednesday said in written reply to the Rajya Sabha."The reason given for the refusal varies from problems in branding to packaging, labelling and adulteration," the minister said.
Elaborating on the steps taken by the government to improve standards and quality to international levels, the minister said: "The steps taken by the government include tightening labelling rules and making it mandatory for companies to clearly mention the dates of manufacturing." "Other steps include improving pre-export inspection, greater emphasis on standards through sensitisation of exporters for compliance of regulatory issues through export promotion agencies and also taking up the issue at bilateral trade forums wherever possible, " Sitharaman said.
"According to refusal report data available on the US Food and Drug Administration (USFDA) website, 11,664 refusals of Indian products were recorded from January 2011 to February 2016," Minister of State for Commerce and Industry Nirmala Sitharaman on Wednesday said in written reply to the Rajya Sabha."The reason given for the refusal varies from problems in branding to packaging, labelling and adulteration," the minister said.
Elaborating on the steps taken by the government to improve standards and quality to international levels, the minister said: "The steps taken by the government include tightening labelling rules and making it mandatory for companies to clearly mention the dates of manufacturing." "Other steps include improving pre-export inspection, greater emphasis on standards through sensitisation of exporters for compliance of regulatory issues through export promotion agencies and also taking up the issue at bilateral trade forums wherever possible, " Sitharaman said.
Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .
Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2020 Minerva Medical Treatment Pvt Ltd